

Understand how Crexont XR works in your brain to treat Parkinson's disease. The dual-bead Carbidopa/Levodopa mechanism explained simply.
To understand how Crexont XR works, you first need to know what's happening in the brain during Parkinson's disease.
Your brain uses a chemical called dopamine to send messages that control movement. In Parkinson's disease, the brain cells that produce dopamine gradually die. As dopamine levels drop, you start experiencing symptoms like tremors, muscle stiffness, slow movement, and difficulty with balance.
Crexont XR works by replacing the dopamine your brain can no longer make on its own.
Crexont XR contains two medications that work together:
Levodopa is the main active ingredient. When you take it, your body converts Levodopa into dopamine. This replenishes the dopamine your brain is missing and helps reduce Parkinson's symptoms like tremors and stiffness.
Levodopa has been used to treat Parkinson's disease since the 1960s and remains the most effective medication for controlling motor symptoms.
Here's the problem with Levodopa on its own: your body starts breaking it down into dopamine before it reaches the brain. Enzymes in your gut and bloodstream convert Levodopa to dopamine in the wrong place, which causes nausea and means less medication gets where it's needed.
Carbidopa solves this problem. It blocks the enzymes that break down Levodopa outside the brain (called peripheral decarboxylase inhibition). This means:
Think of Carbidopa as a bodyguard that protects Levodopa on its journey to your brain.
Several Carbidopa/Levodopa medications exist, including Sinemet (immediate-release), Sinemet CR (controlled-release), and Rytary (extended-release). What makes Crexont XR unique is its dual-bead formulation.
Each Crexont XR capsule contains two types of tiny beads:
These beads contain both Carbidopa and Levodopa. They dissolve quickly after you take the capsule, providing a fast boost of medication. This helps you feel relief from your symptoms sooner — similar to how immediate-release Sinemet works.
These beads contain Levodopa only and are designed to dissolve slowly over time. They release medication gradually, keeping your dopamine levels more steady throughout the day.
Many people with Parkinson's disease experience "wearing off" — a period where their medication stops working before it's time for the next dose. Symptoms come back, and you may feel stiff, slow, or shaky.
Crexont XR's dual-bead design addresses this by:
Here's what happens after you take a Crexont XR capsule:
You may have heard that you should avoid high-protein meals and iron supplements when taking Crexont XR. Here's why:
For more information about what to avoid, read our drug interactions guide.
Here's a simplified comparison:
If you're considering switching medications, see our alternatives guide or talk to your doctor.
Crexont XR works by delivering Levodopa to your brain, where it's converted into dopamine to replace what Parkinson's disease has taken away. Carbidopa protects the Levodopa from being broken down too early. The dual-bead capsule provides both quick relief and extended coverage, helping to reduce wearing-off periods between doses.
Want to know more? Learn about Crexont XR dosage and uses, side effects to watch for, or how to find it at a pharmacy near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.